Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174–86. https://doi.org/10.1038/s41568-019-0238-1.
Article CAS PubMed PubMed Central Google Scholar
Prive BM, Boussihmad MA, Timmermans B, van Gemert WA, Peters SMB, Derks YHW, et al. Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies. Eur J Nucl Med Mol Imaging. 2023;50:1906–18. https://doi.org/10.1007/s00259-023-06144-0.
Article PubMed PubMed Central Google Scholar
Zhang Z, Tao J, Qiu J, Cao Z, Huang H, Xiao J, et al. From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment. Cell Oncol (Dordr). 2023. https://doi.org/10.1007/s13402-023-00872-z.
Giesel FL, Kratochwil C, Lindner T, Marschalek MM, Loktev A, Lehnert W, et al. 68Ga-FAPI PET/CT: Biodistribution and preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting agents in patients with various cancers. J Nucl Med. 2019;60:386–92. https://doi.org/10.2967/jnumed.118.215913.
Article CAS PubMed PubMed Central Google Scholar
Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. 68Ga-FAPI PET/CT: Tracer Uptake in 28 different kinds of Cancer. J Nucl Med. 2019;60:801–5. https://doi.org/10.2967/jnumed.119.227967.
Article CAS PubMed PubMed Central Google Scholar
Toms J, Kogler J, Maschauer S, Daniel C, Schmidkonz C, Kuwert T, et al. Targeting fibroblast activation protein: Radiosynthesis and preclinical evaluation of an 18F-Labeled FAP inhibitor. J Nucl Med. 2020;61:1806–13. https://doi.org/10.2967/jnumed.120.242958.
Article CAS PubMed Google Scholar
Lai C, Cao R, Li R, He C, Wang X, Shi H, et al. Fibroblast activation protein targeting probe with gly-pro sequence for PET of Glioblastoma. Mol Pharm. 2023;20:4120–8. https://doi.org/10.1021/acs.molpharmaceut.3c00248.
Article CAS PubMed Google Scholar
Kersemans K, De Man K, Courtyn J, Van Royen T, Piron S, Moerman L, et al. Automated radiosynthesis of Al[18F]PSMA-11 for large scale routine use. Appl Radiat Isot. 2018;135:19–27. https://doi.org/10.1016/j.apradiso.2018.01.006.
Article CAS PubMed Google Scholar
Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54. https://doi.org/10.1007/s00259-014-2961-x.
Article CAS PubMed Google Scholar
Wasserthal J, Breit HC, Meyer MT, Pradella M, Hinck D, Sauter AW, et al. TotalSegmentator: robust segmentation of 104 anatomic structures in CT images. Radiol Artif Intell. 2023;5:e230024. https://doi.org/10.1148/ryai.230024.
Article PubMed PubMed Central Google Scholar
Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, et al. 3D slicer as an image computing platform for the quantitative Imaging Network. Magn Reson Imaging. 2012;30:1323–41. https://doi.org/10.1016/j.mri.2012.05.001.
Article PubMed PubMed Central Google Scholar
Beichel RR, Van Tol M, Ulrich EJ, Bauer C, Chang T, Plichta KA, et al. Semiautomated segmentation of head and neck cancers in 18F-FDG PET scans: a just-enough-interaction approach. Med Phys. 2016;43:2948–64. https://doi.org/10.1118/1.4948679.
Article PubMed PubMed Central Google Scholar
Sharma V, McNeill JH. To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol. 2009;157:907–21. https://doi.org/10.1111/j.1476-5381.2009.00267.x.
Article CAS PubMed PubMed Central Google Scholar
Demetrius L. Of mice and men. When it comes to studying ageing and the means to slow it down, mice are not just small humans. EMBO Rep. 2005;6:39–44. https://doi.org/10.1038/sj.embor.7400422. Spec No:S.
Wang S, Zhou X, Xu X, Ding J, Liu T, Jiang J, et al. Dynamic PET/CT imaging of 68Ga-FAPI-04 in Chinese subjects. Front Oncol. 2021;11:651005. https://doi.org/10.3389/fonc.2021.651005.
Article CAS PubMed PubMed Central Google Scholar
Kumar S, Borish K, Dey S, Nagesh J, Das A. Sequence dependent folding motifs of the secondary structures of gly-pro and Pro-gly containing oligopeptides. Phys Chem Chem Phys. 2022;24:18408–18. https://doi.org/10.1039/d2cp01306a.
Article CAS PubMed Google Scholar
Minelli A, Conte C, Cacciatore I, Cornacchia C, Pinnen F. Molecular mechanism underlying the cerebral effect of gly-pro-glu tripeptide bound to L-dopa in a Parkinson’s animal model. Amino Acids. 2012;43:1359–67. https://doi.org/10.1007/s00726-011-1210-x.
Article CAS PubMed Google Scholar
Ding H, Liang J, Qiu L, Xu T, Cai L, Wan Q, et al. Prospective comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT for tumor staging in nasopharyngeal carcinoma. Front Oncol. 2022;12:1047010. https://doi.org/10.3389/fonc.2022.1047010.
Article PubMed PubMed Central Google Scholar
Qin C, Liu F, Huang J, Ruan W, Liu Q, Gai Y, et al. A head-to-head comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/MR in patients with nasopharyngeal carcinoma: a prospective study. Eur J Nucl Med Mol Imaging. 2021;48:3228–37. https://doi.org/10.1007/s00259-021-05255-w.
Article CAS PubMed Google Scholar
Wang L, Tang G, Hu K, Liu X, Zhou W, Li H, et al. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the evaluation of Advanced Lung Cancer. Radiology. 2022;303:191–9. https://doi.org/10.1148/radiol.211424.
Li M, Younis MH, Zhang Y, Cai W, Lan X. Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond. Eur J Nucl Med Mol Imaging. 2022;49:2844–68. https://doi.org/10.1007/s00259-022-05706-y.
Article CAS PubMed PubMed Central Google Scholar
Chen R, Yang X, Yu X, Zhou X, Ng YL, Zhao H, et al. Tumor-to-blood ratio for assessment of fibroblast activation protein receptor density in pancreatic cancer using 68Ga-FAPI-04. Eur J Nucl Med Mol Imaging. 2023;50:929–36. https://doi.org/10.1007/s00259-022-06010-5.
Article CAS PubMed Google Scholar
Wang L, Wang Y, Wang J, Xiao M, Xi XY, Chen BX, et al. Myocardial activity at 18F-FAPI PET/CT and risk for Sudden Cardiac Death in Hypertrophic Cardiomyopathy. Radiology. 2023;306:e221052. https://doi.org/10.1148/radiol.221052.
Zhang X, Song W, Qin C, Song Y, Liu F, Hu F, et al. Uterine uptake of 68Ga-FAPI-04 in Uterine Pathology and Physiology. Clin Nucl Med. 2022;47:7–13. https://doi.org/10.1097/RLU.0000000000003968.
Nakamoto Y, Baba S, Kaida H, Manabe O, Uehara T. Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects. Ann Nucl Med. 2024;38:10–9. https://doi.org/10.1007/s12149-023-01873-6.
Pang Y, Zhao L, Luo Z, Hao B, Wu H, Lin Q, et al. Comparison of 68Ga-FAPI and 18F-FDG uptake in gastric, duodenal, and colorectal cancers. Radiology. 2021;298:393–402. https://doi.org/10.1148/radiol.2020203275.
Cai J, Yang D, Sun H, Xiao L, Han F, Zhang M, et al. A multifactorial analysis of FAP to regulate gastrointestinal cancers progression. Front Immunol. 2023;14:1183440. https://doi.org/10.3389/fimmu.2023.1183440.
Article CAS PubMed PubMed Central Google Scholar
Zhao L, Pang Y, Luo Z, Fu K, Yang T, Zhao L, et al. Role of 68Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2021;48:1944–55. https://doi.org/10.1007/s00259-020-05146-6.
Article CAS PubMed Google Scholar
Pure E, Blomberg R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene. 2018;37:4343–57. https://doi.org/10.1038/s41388-018-0275-3.
Article CAS PubMed PubMed Central Google Scholar
Braune A, Oehme L, Freudenberg R, Hofheinz F, van den Hoff J, Kotzerke J, et al. Comparison of image quality and spatial resolution between 18F, 68Ga, and 64Cu phantom measurements using a digital Biograph Vision PET/CT. EJNMMI Phys. 2022;9:58. https://doi.org/10.1186/s40658-022-00487-7.
留言 (0)